Dr. Sennewald
Medizintechnik GmbH

Dr. Sennewald Medizintechnik has over 30 years of experience in the sale of medical technology.

In the context of regional and local hyperthermia in clinical oncology, the company entered into a long-term partnership with the pioneer and world market leader, Pyrexar Medical, to further develop the manufacture of hyperthermia systems. The companies' ties to the scientific community have led to the acceptance of hyperthermia, development of certified software, reimbursement of hyperthermia and its use in pediatric treatment. Phase III studies show that Pyrexar systems lead to a significant increase in cancer response rates. In addition, these systems are the only ones to have received FDA approval.

Our enthusiasm for innovative radiotherapy systems led us to become the exclusive distributor of FLASH radiotherapy systems for the German market in close cooperation with S.I.T. - Sordina IORT Technologies at the beginning of 2024.